ArticleNature communications2026

MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma.

Yun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.